Infection

Trius: dump or double down on maker of MRSA antibiotic?

February 10, 2013 no comments

By Rex Graham The share price of Trius Therapeutics (TSRX) has rebounded from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty ab Read More

Glaxo genital herpes vaccine flops but Agenus a buy in vaccine space

December 14, 2012 1 comment

By Rex Graham A Glaxo Smith Kline (Nasdaq: GSK) genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc. ( Read More

Sangamo applying ‘cure for HIV’ technology to hemophilia,

November 15, 2012 no comments

By Rex Graham The odds of a major advance in the fight against HIV/AIDS have improved with the recent announcement by Sangamo Biosciences (SGMO) that its gene therapy treatment has achieved a “functi Read More

‘Cure for HIV’ in sight, scientists refine research targets

August 3, 2012 no comments

By Rex Graham Pfizer (PFE) has the only FDA-approved drug in a class called CCR5 antagonists, and a “cure for HIV” will most likely focus on CCR5, top scientists agree. If not Pfizer̵ Read More

Vaccine against HIV goal of $77 million NIH grant to Scripps Research

July 11, 2012 no comments

By Mika Ono The Scripps Research Institute LA JOLLA, Calif. – July 11, 2012 – The Scripps Research Institute has been awarded a grant expected to total more than $77 million from the National Institu Read More

Need phylogenetic trees? Got supercomputer app for that

July 3, 2012 no comments

By Rex Graham A new Web resource developed at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego is helping thousands of researchers worldwide unravel the enigmas of Read More

Amid U.S. pertussis outbreak, San Diego battling ‘whooping cough’ with

June 1, 2012 no comments

By Rex Graham Alarmed by pertussis outbreaks this year in children in Washington, Wisconsin, Minnesota, Montana and New Mexico, public health experts in San Diego are using health text messaging to i Read More

Potent antimicrobial peptides in skin — alternative to conventio

May 30, 2012 no comments

By Rex Graham As antibiotic-resistant bacteria have become one of the world’s most pressing public health problems, scientists have found a novel source of antimicrobial peptides: skin cells. Skin ce Read More

Vical genital herpes vaccine protects animals; human clinical testing

May 23, 2012 no comments

By Rex Graham A paper published online May 22 in the Journal of General Virology reports that a genital herpes vaccine made by San Diego-based Vical, Inc. (Nasdaq: VICL) dramatically improved protect Read More

Algae researchers create edible vaccine against malaria

May 16, 2012 no comments

Algae researchers at the University of California, San Diego have engineered potential edible vaccine candidates for malaria. The proof-of-principle experiments could pave the way to the development Read More